COSOPT PF Drug Patent Profile
When do Cosopt Pf patents expire, and when can generic versions of Cosopt Pf launch?
Cosopt Pf is a drug marketed by Thea Pharma and is included in one NDA.
The generic ingredient in COSOPT PF is dorzolamide hydrochloride; timolol maleate. There is one drug master file entry for this compound. Fifteen suppliers are listed for this compound. Additional details are available on the dorzolamide hydrochloride; timolol maleate profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Cosopt Pf
A generic version of COSOPT PF was approved as dorzolamide hydrochloride; timolol maleate by RUBICON RESEARCH on October 28th, 2008.
AI Deep Research
Questions you can ask:
- What is the 5 year forecast for COSOPT PF?
- What are the global sales for COSOPT PF?
- What is Average Wholesale Price for COSOPT PF?
Summary for COSOPT PF
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Finished Product Suppliers / Packagers: | 1 |
| Clinical Trials: | 36 |
| What excipients (inactive ingredients) are in COSOPT PF? | COSOPT PF excipients list |
| DailyMed Link: | COSOPT PF at DailyMed |
Recent Clinical Trials for COSOPT PF
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| Sengi | PHASE4 |
| Prairie Eye Center | PHASE4 |
| Mid Atlantic Retina | Phase 2/Phase 3 |
Pharmacology for COSOPT PF
| Drug Class | Carbonic Anhydrase Inhibitor beta-Adrenergic Blocker |
| Mechanism of Action | Adrenergic beta-Antagonists Carbonic Anhydrase Inhibitors |
US Patents and Regulatory Information for COSOPT PF
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Thea Pharma | COSOPT PF | dorzolamide hydrochloride; timolol maleate | SOLUTION/DROPS;OPHTHALMIC | 202667-001 | Feb 1, 2012 | AT2 | RX | Yes | Yes | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
